Stay updated on Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.6.3 is now shown in the page footer, replacing Revision: v3.6.2. This reflects a minor site update and does not alter the study information presented on the page.SummaryDifference0.0%

- Check12 days agoChange DetectedSite build updated from v3.6.0 to v3.6.2; indicates a new release of the ClinicalTrials.gov interface without altering the study details shown on the page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows 'No longer looking for participants,' indicating recruitment for the study is closed. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), a formatting tweak to the Intervention/Treatment label, and a page revision update to v3.6.0.SummaryDifference0.3%

- Check34 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, indicating a new minor release of the page; the older version tag was removed.SummaryDifference0.0%

- Check48 days agoChange DetectedThe study details page now omits the clinical study report synopsis, the sponsor name AbbVie, and the Helpful Links Provided by header, altering how the study's metadata and navigation are presented.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the ClinicalTrials.gov page, representing a site version update. This change does not modify study content or data presented on the page.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page.